跳至主要内容
临床试验/IRCT20190929044919N1
IRCT20190929044919N1已完成3 期

Comparison of the Effectiveness of 6 mg and 12 mg Adenosine in the Treatment of Paroxysmal Supraventricular Tachycardia

Alborz University of Medical Sciences0 个研究点目标入组 142 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
142

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • The patient should have informed consent to participate in the study
  • The patient has a Paroxysmal Supraventricular Tachycardia
  • The patient's age is in the range of 70-18 years

排除标准

  • The Patient dissatisfaction to participate in the intervention
  • Patient sensitivity to adenosine
  • The patient has first and second degree AV node blocks
  • The patient has sick sinus syndrome
  • The patient has a history of previous seizures and epilepsy

研究者

发起方
Alborz University of Medical Sciences

相似试验